MaxCyte, Inc. (MXCT)
NASDAQ: MXCT · Real-Time Price · USD
2.270
-0.085 (-3.61%)
At close: May 12, 2025, 4:00 PM
2.299
+0.029 (1.29%)
After-hours: May 12, 2025, 6:03 PM EDT
MaxCyte Employees
MaxCyte had 114 employees as of December 31, 2024. The number of employees decreased by 29 or -20.28% compared to the previous year.
Employees
114
Change (1Y)
-29
Growth (1Y)
-20.28%
Revenue / Employee
$330,482
Profits / Employee
-$366,579
Market Cap
248.60M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
MXCT News
- 2 days ago - MaxCyte, Inc. (MXCT) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 5 days ago - MaxCyte Reports First Quarter 2025 Financial Results and Reiterates Full Year 2025 Guidance - GlobeNewsWire
- 4 weeks ago - MaxCyte to Report First Quarter 2025 Financial Results on May 7, 2025 - GlobeNewsWire
- 2 months ago - MaxCyte: Strong Revenues, Fast-Growing Cell-Therapy Market, Very Low Share Price - Seeking Alpha
- 2 months ago - MaxCyte, Inc. (MXCT) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - MaxCyte Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Guidance - GlobeNewsWire
- 3 months ago - MaxCyte Signs Strategic Platform License with TG Therapeutics to Advance its Autoimmune Cell Therapeutics Programs - GlobeNewsWire
- 3 months ago - MaxCyte to Report Fourth Quarter and Full Year 2024 Financial Results on March 11, 2025, and Participate in Upcoming Investor Conference - GlobeNewsWire